Literature DB >> 24201366

Phosphodiesterase activities in transgenic tobacco plants associated with the movement protein of tobacco mosaic virus.

M Perl1, R Gafni, R N Beachy.   

Abstract

Hydrolytic activities of leaf extracts from normal and transgenic plants, with (+ MP) and without (-MP) the movement protein of tobacco mosaic virus, were examined. In the + MP transgenic plants, as compared with non-transgenic and - MP plants, higher hydrolytic activities were found on the following substrates: bis-(nitrophenyl)-phosphate (BPNPP, phosphodiesterase), p-nitrophenyl-(phenyl)-phosphate (PNPPP, nucleotidephosphodiesterase) and thymidine-3'-monophosphate p-nitrophenyl ester (T3MPP; 3'nucleotide phosphodiesterase.) The + MP plant lines, as compared with other transgenic plants, exhibited higher nucleotide-phosphodiesterase activity in the soluble as well as in the membrane fraction. Substrate concentration kinetic studies revealed the presence of a nucleotide-phospho-diesterase with a high substrate affinity in the +MP extracts in addition to the enzyme with a relatively low substrate affinity present also in the - MP transgenic plants. This "high affinity" enzyme could be removed from the soluble fraction by precipitation with anti-MP serum, indicating its possible association with the movement protein.

Entities:  

Year:  1992        PMID: 24201366     DOI: 10.1007/BF00224177

Source DB:  PubMed          Journal:  Theor Appl Genet        ISSN: 0040-5752            Impact factor:   5.699


  11 in total

1.  Messenger RNA for the coat protein of tobacco mosaic virus.

Authors:  T R Hunter; T Hunt; J Knowland; D Zimmern
Journal:  Nature       Date:  1976-04-29       Impact factor: 49.962

2.  Movement protein of tobacco mosaic virus modifies plasmodesmatal size exclusion limit.

Authors:  S Wolf; C M Deom; R N Beachy; W J Lucas
Journal:  Science       Date:  1989-10-20       Impact factor: 47.728

3.  Synthesis of TMV-specific RNAs and proteins at the early stage of infection in tobacco protoplasts: transient expression of the 30K protein and its mRNA.

Authors:  Y Watanabe; Y Emori; I Ooshika; T Meshi; T Ohno; Y Okada
Journal:  Virology       Date:  1984-02       Impact factor: 3.616

4.  Molecular characterization and biological function of the movement protein of tobacco mosaic virus in transgenic plants.

Authors:  C M Deom; K R Schubert; S Wolf; C A Holt; W J Lucas; R N Beachy
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Phosphorylative inactivation of aminoglycosidic antibiotics by Escherichia coli carrying R factor.

Authors:  H Umezawa; M Okanishi; S Kondo; K Hamana; R Utahara; K Maeda; S Mitsuhashi
Journal:  Science       Date:  1967-09-29       Impact factor: 47.728

6.  The problems of drug-resistant pathogenic bacteria. R factors: biochemical mechanisms of resistance to aminoglycoside antibiotics.

Authors:  J Davies; M Brzezinska; R Benveniste
Journal:  Ann N Y Acad Sci       Date:  1971-06-11       Impact factor: 5.691

7.  The P30 movement protein of tobacco mosaic virus is a single-strand nucleic acid binding protein.

Authors:  V Citovsky; D Knorr; G Schuster; P Zambryski
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

8.  Delay of disease development in transgenic plants that express the tobacco mosaic virus coat protein gene.

Authors:  P P Abel; R S Nelson; B De; N Hoffmann; S G Rogers; R T Fraley; R N Beachy
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

9.  Localization by immunogold cytochemistry of the virus-coded 30K protein in plasmodesmata of leaves infected with tobacco mosaic virus.

Authors:  K Tomenius; D Clapham; T Meshi
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

10.  The tobacco mosaic virus 30K movement protein in transgenic tobacco plants is localized to plasmodesmata.

Authors:  D Atkins; R Hull; B Wells; K Roberts; P Moore; R N Beachy
Journal:  J Gen Virol       Date:  1991-01       Impact factor: 3.891

View more
  1 in total

1.  Erectogenic Effects of Clerodendron capitatum: Involvement of Phosphodiesterase Type-5 Inhibition.

Authors:  Siddig Ibrahim Abdelwahab; Abdelwahab Hassan Mohamed; Osama Yousif Mohamed; Mahjoub Oall; Manal Mohamed Elhassan Taha; Syam Mohan; Mohamed Ibrahim Noordin; Mohd Rais Mustafa; Khalid M Alkharfy
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-13       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.